These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26867161)

  • 1. Do no harm: no psychological harm from colorectal cancer screening.
    Kirkøen B; Berstad P; Botteri E; Åvitsland TL; Ossum AM; de Lange T; Hoff G; Bernklev T
    Br J Cancer; 2016 Mar; 114(5):497-504. PubMed ID: 26867161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological effects of colorectal cancer screening: Participants
    Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
    World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in health behavior 1 year after testing negative at a colorectal cancer screening: a randomized-controlled study.
    Knudsen MD; Hjartåker A; Olsen MKE; Hoff G; de Lange T; Bernklev T; Berstad P
    Eur J Cancer Prev; 2018 Jul; 27(4):316-322. PubMed ID: 27824661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of two colorectal cancer screening tests: pain as a key determinant in sigmoidoscopy.
    Kirkøen B; Berstad P; Botteri E; Dalén E; Nilsen JA; Hoff G; de Lange T; Bernklev T
    Endoscopy; 2017 Nov; 49(11):1075-1086. PubMed ID: 28938500
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening.
    Vermeer NCA; van der Valk MJM; Snijders HS; Vasen HFA; Gerritsen van der Hoop A; Guicherit OR; Liefers GJ; van de Velde CJH; Stiggelbout AM; Peeters KCMJ
    Psychooncology; 2020 Jun; 29(6):1084-1091. PubMed ID: 32237002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Psychological Impact of a Colorectal Cancer Diagnosis Following a Negative Fecal Occult Blood Test Result.
    Miles A; McClements PL; Steele RJ; Redeker C; Sevdalis N; Wardle J
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1032-8. PubMed ID: 25924826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
    Senore C; Ederle A; DePretis G; Magnani C; Canuti D; Deandrea S; Zorzi M; Barca A; Bestagini P; Faitini K; Bisanti L; Casale C; Ferro A; GiorgiRossi P; Quadrino F; Fiorina G; Capuano A; Segnan N; Fantin A
    Prev Med; 2015 Apr; 73():106-11. PubMed ID: 25602908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in participants of a CRC screening program.
    Kapidzic A; Korfage IJ; van Dam L; van Roon AH; Reijerink JC; Zauber AG; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Br J Cancer; 2012 Oct; 107(8):1295-301. PubMed ID: 22955850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
    Knudsen MD; Berstad P; Hjartåker A; Gulichsen EH; Hoff G; de Lange T; Bernklev T; Botteri E
    Br J Cancer; 2017 Aug; 117(4):461-469. PubMed ID: 28704841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial.
    Berstad P; Løberg M; Larsen IK; Kalager M; Holme Ø; Botteri E; Bretthauer M; Hoff G
    Gut; 2015 Aug; 64(8):1268-76. PubMed ID: 25183203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.
    Denters MJ; Bossuyt PM; Deutekom M; Fockens P; Dekker E
    Eur J Cancer Prev; 2015 May; 24(3):176-9. PubMed ID: 25734239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological distress following fecal occult blood test in colorectal cancer screening--a population-based study.
    Brasso K; Ladelund S; Frederiksen BL; Jørgensen T
    Scand J Gastroenterol; 2010 Oct; 45(10):1211-6. PubMed ID: 20443744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme.
    Hol L; Kuipers EJ; van Ballegooijen M; van Vuuren AJ; Reijerink JC; Habbema DJ; van Leerdam ME
    Int J Cancer; 2012 May; 130(9):2096-102. PubMed ID: 21702046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.